NCT00735501View on ClinicalTrials.gov

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

314

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Start dose and frequency as well as dose alterations to be determined by the physician according to normal clinical evaluation

Trial Locations (2)

2300

Copenhagen S

182 88

Stockholm

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00735501 - Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter